STOCK TITAN

InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle Cartridges

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

InMode (NASDAQ: INMD) has secured a significant legal victory against counterfeit sellers on DHGate platform. The US District Court for the Central District of California has granted InMode a permanent injunction and damages against defendants selling counterfeit Morpheus8 radio frequency microneedling devices and needle cartridges. The court ruling includes freezing the defendants' assets and halting their product listings.

The decision favors InMode on all claims including trademark infringement, false designation of origin, and California unfair competition. To combat counterfeiting, InMode has launched a Verified Provider Program for Morpheus8, enabling certified clinics to demonstrate their authenticity. Patients can verify authorized providers through InMode's Find a Provider tool at www.inmodemd.com.

Loading...
Loading translation...

Positive

  • None.

Negative

  • Presence of counterfeit products in the market indicates potential revenue loss and brand reputation risks

News Market Reaction

+0.35%
1 alert
+0.35% News Effect

On the day this news was published, INMD gained 0.35%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

IRVINE, Calif., May 6, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, reports that the US District Court for the Central District of California granted InMode's motion for default judgment against the DHGate sellers and awarded InMode a permanent injunction and damages for the defendants' sales and promotion of counterfeit goods.

The Court's decision aims to protect safety and uphold InMode's trademark rights. The injunction includes freezing the assets and halting the listings of the sellers involved in the counterfeit trade. The ruling favors InMode on all claims (trademark infringement, false designation of origin, and California unfair competition), and (1) granted a permanent injunction enjoining the sellers from infringing upon the MORPHEUS® and INMODE® trademarks, and (2) awarded InMode damages per defendant.

"InMode maintains a zero-tolerance policy towards fraudulent business practices including counterfeit goods and for any platforms or sellers who are using, selling, or distributing false products," says Moshe Mizrahy, CEO of InMode. "We are committed to public safety and will continue to protect consumers from potential harm caused by unauthorized Morpheus8 devices."

InMode has established a Verified Provider Program for Morpheus8, allowing certified clinics to showcase their authenticity and confirm they use genuine Morpheus8 technology. This initiative helps patients identify safe, authorized providers committed to delivering trusted InMode results.

Patients in the United States of America and Canada seeking top-quality care from an authorized InMode provider using a trademarked Morpheus8 device can visit the Find a Provider tool at www.inmodemd.com.

About InMode 

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

Press Contact:
Behrman Cesa Communications
inmode@behrmancesa.com

Investor Contact:
MS-IR LLC
Miri Segal – Scharia
ir@inmodemd.com
Tel: 917-607-8654

Logo - https://mma.prnewswire.com/media/1064477/5298285/InMode_Logo.jpg

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-granted-injunction-against-counterfeit-sales-of-morpheus8-radio-frequency-microneedling-devices-and-needle-cartridges-302446235.html

SOURCE InMode Ltd.

FAQ

What legal action did InMode (INMD) win against counterfeit sellers?

InMode won a permanent injunction and damages against DHGate sellers in the US District Court for the Central District of California, including asset freezing and halting of counterfeit product listings.

How can patients verify authentic Morpheus8 providers for InMode treatments?

Patients can verify authentic providers through InMode's Verified Provider Program and using the Find a Provider tool at www.inmodemd.com.

What claims did InMode win in the counterfeit case?

InMode won on all claims including trademark infringement, false designation of origin, and California unfair competition.

What measures has InMode implemented to combat counterfeit Morpheus8 devices?

InMode has implemented a zero-tolerance policy against fraudulent practices and established a Verified Provider Program for Morpheus8 to help patients identify authorized providers.
Inmode Ltd.

NASDAQ:INMD

INMD Rankings

INMD Latest News

INMD Latest SEC Filings

INMD Stock Data

993.02M
56.48M
15.35%
59.25%
5.46%
Medical Devices
Healthcare
Link
Israel
Yokne'am